ALBO Albireo Pharma Inc

Price (delayed)

$33.2

Market cap

$637.27M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.82

Enterprise value

$429.92M

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and ...

Highlights
The equity has increased by 30% year-on-year but it has declined by 18% since the previous quarter
The gross profit has contracted by 18% YoY but it has grown by 5% from the previous quarter
The net income has dropped by 55% year-on-year and by 11% since the previous quarter
Albireo Pharma's EPS has decreased by 16% YoY

Key stats

What are the main financial stats of ALBO
Market
Shares outstanding
19.19M
Market cap
$637.27M
Enterprise value
$429.92M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.29
Price to sales (P/S)
72.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
49.27
Earnings
Revenue
$8.73M
EBIT
-$106.5M
EBITDA
-$106.31M
Free cash flow
-$111.95M
Per share
EPS
-$6.82
Free cash flow per share
-$5.85
Book value per share
$7.74
Revenue per share
$0.46
TBVPS
$12.16
Balance sheet
Total assets
$249.82M
Total liabilities
$101.9M
Debt
$9.74M
Equity
$147.92M
Working capital
$203.75M
Liquidity
Debt to equity
0.07
Current ratio
10.17
Quick ratio
9.77
Net debt/EBITDA
1.95
Margins
EBITDA margin
-1,218.4%
Gross margin
100%
Net margin
-1,374%
Operating margin
-1,220.6%
Efficiency
Return on assets
-46.5%
Return on equity
-76.1%
Return on invested capital
-2,887.1%
Return on capital employed
-46.8%
Return on sales
-1,220.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALBO stock price

How has the Albireo Pharma stock price performed over time
Intraday
0.97%
1 week
2.79%
1 month
11.04%
1 year
27.4%
YTD
-11.49%
QTD
-5.82%

Financial performance

How have Albireo Pharma's revenue and profit performed over time
Revenue
$8.73M
Gross profit
$8.73M
Operating income
-$106.5M
Net income
-$119.88M
Gross margin
100%
Net margin
-1,374%
The net margin has dropped by 88% year-on-year and by 6% since the previous quarter
ALBO's operating margin has dropped by 72% year-on-year and by 5% since the previous quarter
The net income has dropped by 55% year-on-year and by 11% since the previous quarter
The company's operating income fell by 41% YoY and by 11% QoQ

Growth

What is Albireo Pharma's growth rate over time

Valuation

What is Albireo Pharma stock price valuation
P/E
N/A
P/B
4.29
P/S
72.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
49.27
Albireo Pharma's EPS has decreased by 16% YoY
ALBO's price to book (P/B) is 48% higher than its 5-year quarterly average of 2.9 and 13% higher than its last 4 quarters average of 3.8
The equity has increased by 30% year-on-year but it has declined by 18% since the previous quarter
The price to sales (P/S) is 99% lower than the 5-year quarterly average of 10055.0 but 27% higher than the last 4 quarters average of 57.1
The revenue has contracted by 18% YoY but it has grown by 5% from the previous quarter

Efficiency

How efficient is Albireo Pharma business performance
Albireo Pharma's return on sales has shrunk by 81% YoY and by 5% QoQ
Albireo Pharma's return on invested capital has increased by 18% QoQ
Albireo Pharma's return on equity has decreased by 5% QoQ and by 4.5% YoY
Albireo Pharma's return on assets has decreased by 5% YoY and by 4% QoQ

Dividends

What is ALBO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALBO.

Financial health

How did Albireo Pharma financials performed over time
The total assets is 145% more than the total liabilities
ALBO's total liabilities is up by 48% year-on-year but it is down by 2.4% since the previous quarter
The total assets has grown by 37% YoY but it has contracted by 13% from the previous quarter
The debt is 93% smaller than the equity
The debt to equity has grown by 40% since the previous quarter
The equity has increased by 30% year-on-year but it has declined by 18% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.